"Huntingtin Holiday": Progress toward an Antisense Therapy for Huntington's Disease

被引：41
|
作者：
Lu, Xiao-Hong [1 ,2 ,3 ]
Yang, X. William [1 ,2 ,3 ]
机构：
[1] Univ Calif Los Angeles, David Geffen Sch Med, Ctr Neurobehav Genet, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Inst Brain Res, Los Angeles, CA 90095 USA
来源：
NEURON | 2012年 / 74卷 / 06期
关键词：
MUTANT HUNTINGTIN; MOUSE MODEL; MICE; OLIGONUCLEOTIDES; NEUROPATHOLOGY; PATHOGENESIS; BRAIN; MOTOR;
D O I：
10.1016/j.neuron.2012.06.001
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
Lowering mutant Huntingtin is a consensus therapeutic strategy for Huntington's disease. In this issue of Neuron, Kordasiewicz et al. (2012) show the benefit of transient antisense oligonucleotide (ASO) therapy to degrade Huntingtin mRNA and elicit sustained therapeutic benefit in HD mice.
引用
收藏
页码：964 / 966
页数：3
相关论文
共 50 条
  • [1] Redirecting Huntingtin protein may be the key to Huntington's disease therapy
    不详
    FUTURE NEUROLOGY, 2007, 2 (02) : 140 - 140
  • [2] Drug holiday in Huntington's disease
    Schmidt, EZ
    Hofmann, P
    Kapfhammer, HP
    Bonelli, RM
    ANNALS OF PHARMACOTHERAPY, 2005, 39 (04) : 773 - 773
  • [3] Huntingtin aggregation and toxicity in Huntington's disease
    Bates, G
    LANCET, 2003, 361 (9369): : 1642 - 1644
  • [4] Normal huntingtin function in Huntington's disease
    Cattaneo, E.
    EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 : 13 - 13
  • [5] HUNTINGTON'S DISEASE Flipping a switch on huntingtin
    Greiner, Erin R.
    Yang, X. William
    NATURE CHEMICAL BIOLOGY, 2011, 7 (07) : 412 - 415
  • [6] Nucleocytoplasmic transport of huntingtin and Huntington's disease
    Truant, R
    CLINICAL NEUROSCIENCE RESEARCH, 2003, 3 (03) : 157 - 164
  • [7] Allele-Specific Silencing of Mutant Huntingtin for Huntington's Disease Therapy
    Mas-Monteys, Alex
    Harper, Scott Q.
    Gilmore, Brian L.
    Staber, Patrick D.
    Schaffer, Chris
    Polisky, Barry
    Vargeese, Chandra
    Davidson, Beverly L.
    MOLECULAR THERAPY, 2006, 13 : S274 - S275
  • [8] Huntingtin-Lowering Strategies in Huntington's Disease: Antisense Oligonucleotides, Small RNAs, and Gene Editing
    Aronin, Neil
    DiFiglia, Marian
    MOVEMENT DISORDERS, 2014, 29 (11) : 1455 - 1461
  • [9] Selection of an AAV gene therapy targeting huntingtin for the treatment of Huntington's disease
    Sah, D.
    Zhou, P.
    Chen, F.
    Wang, X.
    Christensen, E.
    Thompson, J.
    Nonnenmacher, M.
    Scheel, M.
    Ren, X.
    Wang, W.
    Zhou, X.
    Stanek, L.
    Mastis, B.
    Pechan, P.
    Horowitz, E.
    Dismuke, D.
    Kells, A.
    Carter, T.
    Hou, J.
    HUMAN GENE THERAPY, 2017, 28 (12) : A74 - A75
  • [10] Moving toward a gene therapy for Huntington’s disease
    J C Glorioso
    J B Cohen
    D L Carlisle
    I Munoz-Sanjuan
    R M Friedlander
    Gene Therapy, 2015, 22 : 931 - 933
12345